2ccs: Difference between revisions

Line 1:

[[Image:2ccs.~~gif~~|left|200px]]

[[Image:2ccs.png|left|200px]]

<!--

Line 9:

Line 10:

~~'''~~HUMAN HSP90 WITH 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-3-YL)-BENZENE-1,2-DIOL~~'''~~

===HUMAN HSP90 WITH 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-3-YL)-BENZENE-1,2-DIOL===

~~==Overview==~~

<!--

~~Novel piperazinyl~~, ~~morpholino and piperidyl derivatives of the pyrazole-based Hsp90 inhibitor CCT018159 are described. Structure-activity relationships have been elucidated by X-ray co-crystal analysis of~~ the ~~new compounds bound~~ to the ~~N-terminal domain of human Hsp90~~. ~~Key features of the binding mode are essentially identical to the recently reported potent analogue VER-49009~~. ~~The most potent of the new compounds has a methylsulfonylbenzyl substituent appended to the piperazine nitrogen~~, ~~possesses an IC50 of less than 600 nM binding against~~ the ~~enzyme and demonstrates low micromolar inhibition of tumour cell proliferation~~.

The line below this paragraph, {{ABSTRACT_PUBMED_16480864}}, adds the Publication Abstract to the page

(as it appears on PubMed at http://www.pubmed.gov), where 16480864 is the PubMed ID number.

-->

==About this Structure==

Line 44:

Line 48:

[[Category: Phosphorylation]]

[[Category: Pyrazole]]

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on ~~Sat May 3 21~~:49:44 2008''

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 11:23:37 2008''

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
-[[Image:2ccs.gif|left|200px]]
+{{Seed}}
+[[Image:2ccs.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2ccs|  PDB=2ccs  |  SCENE=  }}
-'''HUMAN HSP90 WITH 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-3-YL)-BENZENE-1,2-DIOL'''
+===HUMAN HSP90 WITH 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-3-YL)-BENZENE-1,2-DIOL===
-==Overview==
+<!--
-Novel piperazinyl, morpholino and piperidyl derivatives of the pyrazole-based Hsp90 inhibitor CCT018159 are described. Structure-activity relationships have been elucidated by X-ray co-crystal analysis of the new compounds bound to the N-terminal domain of human Hsp90. Key features of the binding mode are essentially identical to the recently reported potent analogue VER-49009. The most potent of the new compounds has a methylsulfonylbenzyl substituent appended to the piperazine nitrogen, possesses an IC50 of less than 600 nM binding against the enzyme and demonstrates low micromolar inhibition of tumour cell proliferation.
+The line below this paragraph, {{ABSTRACT_PUBMED_16480864}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 16480864 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_16480864}}
 ==About this Structure==
@@ Line 44: / Line 48: @@
 [[Category: Phosphorylation]]
 [[Category: Pyrazole]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 21:49:44 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 11:23:37 2008''